Genmab (GMAB) Event Aug. 05, 2022, 03:47 UTC 38 Genmab and BioNTech Expand Global Strategic Collaboration to Develop and Commercialize Novel Immunotherapy Candidates Comment Full text
Protagonist Therapeutics Inc (PTGX) Event Aug. 04, 2022, 14:17 UTC 40 Protagonist Therapeutics, Inc - Corporate Presentation Comment Full text
Geron Corporation Inc (GERN) Event Aug. 04, 2022, 13:31 UTC 39 Geron - Q2 2022 Geron Earnings Conference Call Comment Full text
NanoString Technologies Inc. (NSTG) Event Aug. 04, 2022, 13:04 UTC 37 NanoString Technologies, Inc. - Nanostring 2022 Second Quarter Financial Results Comment Full text
Mirum Pharmaceuticals Inc. (MIRM) Event Aug. 04, 2022, 13:03 UTC 40 Mirum Pharma - Corporate Presentation – August 2022 Comment Full text
Cytokinetics Inc (CYTK) Event Aug. 04, 2022, 13:01 UTC 37 Cytokinetics Reports Second Quarter 2022 Financial Results Comment Full text
Rain Therapeutics Inc. (RAIN) Event Aug. 04, 2022, 05:01 UTC 34 Rain Therapeutics Announces Completion of Enrollment in Phase 3 MANTRA Trial for Milademetan in Liposarcoma Comment Full text
Cytokinetics Inc (CYTK) Event Aug. 04, 2022, 04:32 UTC 38 Cytokinetics and The ALS Association Announce Release of Updated PRO-ACT Database Including Data From Cytokinetics’ Completed ALS Clinical Trials Comment Full text
Passage Bio Inc. (PASG) Event Aug. 04, 2022, 04:04 UTC 38 Passage Bio, Inc. - Corporate Presentation - August 2022 Comment Full text